These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7977020)

  • 1. Update on erythropoietin.
    Mason NA
    Am Pharm; 1994 Sep; NS34(9):16-8. PubMed ID: 7977020
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin patient dosing algorithm.
    Muirhead N
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):59-65. PubMed ID: 2192418
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin.
    Finn M
    Int J Artif Organs; 1989 May; 12(5):282-3. PubMed ID: 2737767
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answers.
    Mittelman M
    Acta Haematol; 1993; 90(2):53-7. PubMed ID: 8285018
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin to prevent transfusions in premature infants.
    Alfaleh K; Thabane L
    J Perinatol; 2005 Aug; 25(8):560. PubMed ID: 16047037
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
    Boran M; Dalva I; Yazicioğlu A; Cetin S
    Nephron; 1993; 63(1):113-4. PubMed ID: 8446239
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin.
    Beresford CH
    N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
    Fine RN
    Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.
    Obladen M; Maier R; Segerer H; Grauel EL; Holland BM; Stewart G; Jorch G; Rabe H; Linderkamp O; Hoffmann HG
    Contrib Nephrol; 1991; 88():314-26. PubMed ID: 2040194
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis.
    Murphy EA; Bell AL; Wojtulewski J; Brzeski M; Madhok R; Capell HA
    BMJ; 1994 Nov; 309(6965):1337-8. PubMed ID: 7866082
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythropoietin and subarachnoid hemorrhage.
    Grasso G; Sfacteria A
    J Neurosurg; 2010 Mar; 112(3):699-700. PubMed ID: 20192676
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients.
    Lago M; Pérez-García R; García de Vinuesa MS; Anaya F; Valderrábano F
    Nephron; 1996; 72(4):723-4. PubMed ID: 8730458
    [No Abstract]   [Full Text] [Related]  

  • 18. rhEPO treatment of anemia in uremic patients.
    Bommer J; Barth HP; Schwöbel B
    Contrib Nephrol; 1990; 87():59-67. PubMed ID: 2093542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
    Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
    Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis during rapid growth. Role of erythropoietin and nutrition.
    Bechensteen AG; Halvorsen S; Hågå P
    Ann N Y Acad Sci; 1994 Apr; 718():339-40. PubMed ID: 8185241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.